Markus Bürgle

The urokinase plasminogen activator system as a novel target for tumour therapy

Manfred Schmitt, Olaf G. Wilhelm, Ute Reuning et al. · Fibrinolysis & proteolysis/Fibrinolysis and proteolysis · 2000 · 108 citations

Medicine, Cancer Biology, Oncology +14

Inhibition of the Interaction of Urokinase-Type Plasminogen Activator (uPA) with Its Receptor (uPAR) by Synthetic Peptides

Markus Bürgle, Marcus Koppitz, Christoph Riemer et al. · Biological Chemistry · 1997 · 65 citations

Life Sciences, Biochemistry, Cell Signaling +5

Synthesis, Solution Structure, and Biological Evaluation of Urokinase Type Plasminogen Activator (uPA)-Derived Receptor Binding Domain Mimetics

Niko Schmiedeberg, Manfred Schmitt, Christian Rölz et al. · Journal of Medicinal Chemistry · 2002 · 42 citations · Full text

Medicine, Oncology, Pharmacology +13

A Novel Type of Bifunctional Inhibitor Directed against Proteolytic Activity and Receptor/Ligand Interaction

Bernd Muehlenweg, Irmgard Assfalg‐Machleidt, S.G. Parrado et al. · Journal of Biological Chemistry · 2000 · 40 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +14

Cyclo19,31[D-Cys19]-uPA19-31 Is a Potent Competitive Antagonist of the Interaction of Urokinase-Type Plasminogen Activator with Its Receptor (CD87)

Viktor Magdolen, Markus Bürgle, Nuria Arroyo de Prada et al. · Biological Chemistry · 2001 · 32 citations

Medicine, Cell Biology, Oncology +10